Hepion Pharmaceuticals, Inc. (HEPA) — SEC Filings
Hepion Pharmaceuticals, Inc. (HEPA) — 2 SEC filings. Latest: ARS (Apr 28, 2026). Includes 1 4, 1 ARS.
View Hepion Pharmaceuticals, Inc. on SEC EDGAR
Overview
Hepion Pharmaceuticals, Inc. (HEPA) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a ARS filed on Apr 28, 2026: Hepion Pharmaceuticals, Inc. filed its Annual Report to Security Holders (ARS) on April 28, 2026, for the period ending December 31, 2025. The company, headquartered in Red Bank, NJ, is involved in the pharmaceutical preparations industry. This filing provides a summary of the company's performance
Sentiment Summary
Across 2 filings, the sentiment breakdown is: 2 neutral. The dominant filing sentiment for Hepion Pharmaceuticals, Inc. is neutral.
Filing Type Overview
Hepion Pharmaceuticals, Inc. (HEPA) has filed 1 4, 1 ARS with the SEC between Apr 2026.
Recent SEC Filings (2)
| Date | Form | Description | Risk |
|---|---|---|---|
| Apr 28, 2026 | ARS | Hepion Pharmaceuticals Files 2025 Annual Report | low |
| Apr 27, 2026 | 4 | 4 Filing |
Risk Profile
Risk Assessment: Of HEPA's 1 recent filings, 0 were flagged as high-risk, 0 as medium-risk, and 1 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Top Tags
annual-report (1) · pharmaceuticals (1) · sec-filing (1)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Fiscal Year End | 2025 | Period covered by the ARS filing |
| ARS Document Size | 739081 | Size of the ARS PDF document |
Frequently Asked Questions
What are the latest SEC filings for Hepion Pharmaceuticals, Inc. (HEPA)?
Hepion Pharmaceuticals, Inc. has 2 recent SEC filings from Apr 2026, including 1 4, 1 ARS. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of HEPA filings?
Across 2 filings, the sentiment breakdown is: 2 neutral. The dominant sentiment is neutral.
Where can I find Hepion Pharmaceuticals, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Hepion Pharmaceuticals, Inc. (HEPA) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Hepion Pharmaceuticals, Inc.?
Financial highlights for Hepion Pharmaceuticals, Inc. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for HEPA?
Investment thesis data for HEPA will be available once enriched filings are processed.
Who are the key executives at Hepion Pharmaceuticals, Inc.?
Executive information for Hepion Pharmaceuticals, Inc. is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Hepion Pharmaceuticals, Inc. stock?
Of HEPA's 1 assessed filings, 0 were flagged high-risk, 0 medium-risk, and 1 low-risk.
What are recent predictions and forward guidance from Hepion Pharmaceuticals, Inc.?
Forward guidance and predictions for Hepion Pharmaceuticals, Inc. are extracted from SEC filings as they are enriched.